Azatadine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C20H22N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94Z39NID6C, chemically known as 6,11-dihydro-11-(1-methyl-4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridine but generally known as azatadine, which bears US NIH Compound Identifier 19861. Azatadine most often comes in base, dimaleate, and maleate forms. European Medicines Agency schedules Azatadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05645MIG. The term AZATADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules azatadine in its Anatomical Therapeutic Chemical (ATC) Classification. AZATADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azatadine under HS 29333999 and SITC 51574. As of Q4 2014, AZATADINE remains the US FDA Preferred Term for this commodity. Azatadine bears US NLM identifiers UMLS ID C0052759 and NCI Concept Code C77430. SMILES: N1(CC/C(=C2/C3C(CCC4C2NCCC4)CCCC3)CC1)C.